Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)
This study has been completed.
Study NCT00088088 Information provided by Synta Pharmaceuticals Corp.
First Received on July 20, 2004. Last Updated on December 3, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Stage IV Non-Small Cell Lung Cancer
Additional conditions recognized in this trial
Carcinoma, Non-Small-Cell Lung
More general conditions related to this trial
Neoplasms by Site
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Interventions listed in this trial
More general drug interventions related to this trial
Antineoplastic Agents, Phytogenic
Molecular Mechanisms of Pharmacological Action
Sponsors listed in this trial
Synta Pharmaceuticals Corp.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers